Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Clean Energy Empowerment Zone Act of 2011
Client: WINE AND SPIRITS WHOLESALERS OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
Support state-based alcohol regulation systems, H.R. 1611, The Care Act.
Clean Energy Empowerment Zone Act of 2011
Client: WINE AND SPIRITS WHOLESALERS OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
Support state-based alcohol regulation systems, H.R. 1611, The Care Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Medicare prescription drug benefit. Drug rebates for Medicare Part D.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRINKS COMPANY via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Source: Senate LDA
| GOLDMAN SACHS |
| 18 |
| 2002–2009 |
| THE INTERNET & TELEVISION ASSN (FORMERLY NTL CABLE & TELECOMMUNICATIONS ASSN) | 18 | 2006–2011 |
| TYCO ELECTRONICS | 17 | 2007–2011 |
| UNITED AIRLINES, INC | 17 | 2006–2011 |
| CELLULAR BIOENGINEERING INC | 16 | 2006–2011 |
| NATIONAL ASSN OF STATE TREASURERS (NAST) | 16 | 2007–2011 |
| LEATHERMAN TOOL GROUP, INC. | 15 | 2007–2011 |
| VICTORINOX SWISS ARMY | 15 | 2007–2011 |
| COCA-COLA COMPANY | 14 | 2007–2011 |
| COLUMBUS REGIONAL AIRPORT AUTHORITY | 14 | 2006–2011 |
| PFIZER | 14 | 2008–2011 |
| HONOLULU AUTH. FOR RAPID TRNS. (PREVIOUSLY KNOWN AS INFRACONSULT, LLC.) | 13 | 2008–2011 |
| ZIPPO MANUFACTURING COMPANY | 13 | 2006–2011 |
| POPULATION COUNCIL | 12 | 2005–2009 |
| EXPRESS SERVICES | 11 | 2007–2009 |
| NORFOLK SOUTHERN CORPORATION | 11 | 2008–2011 |
| OWENS-ILLINOIS INC | 11 | 2008–2010 |
| VISA | 11 | 2008–2011 |
| WINE AND SPIRITS WHOLESALERS OF AMERICA | 11 | 2008–2011 |
| BRIGHT HOUSE NETWORKS | 10 | 2009–2011 |
| COMCAST CORPORATION | 10 | 2009–2011 |
| COUNTY OF MAUI- HAWAII | 10 | 2009–2011 |
| AMERICAN RED CROSS, CINCINNATI AREA CHAPTER | 9 | 2009–2010 |
| BRINKS COMPANY | 9 | 2009–2011 |
| INTERNATIONAL SPEEDWAY CORPORATION | 9 | 2005–2008 |
| FP2 INC. | 8 | 2009–2011 |
| GE GLOBAL SIGNALING | 8 | 2002–2007 |
| MOTOROLA | 8 | 2004–2007 |
| NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS | 8 | 2007–2009 |
| NATIONAL COUNCIL ON ECONOMIC EDUCATION | 8 | 2003–2008 |
| Time Warner Inc. | 8 | 2006–2008 |
| PARSONS BRINCKERHOFF QUADE & DOUGLAS | 7 | 2005–2008 |
| AMERICAN MAGLEV TECHNOLOGY, INC. | 6 | 2009–2010 |
| BAYER CORPORATION | 6 | 2009–2010 |
| CALHOUN COMMUNITY COLLEGE | 6 | 2005–2007 |
| MARYLAND DEPT OF TRANSPORTATION | 6 | 2004–2006 |
| SSFM INTL | 6 | 2002–2005 |
| AIR MEDICAL OPERATORS ASSOCIATION | 5 | 2009 |
| ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) | 5 | 2010–2011 |
| BAPTIST CHILD AND FAMILY SERVICES | 5 | 2009–2010 |
| CASH AMERICA INTERNATIONAL, INC. | 5 | 2010–2011 |
| GENENTECH INC | 5 | 2010–2011 |
| MEMORIAL HEALTH UNIV MEDICAL CENTER | 5 | 2005–2007 |
| TRANSAMERICA COMPANIES (FORMLY AEGON) | 5 | 2004–2011 |
| BOMBARDIER TRANSPORTATION | 4 | 2002–2003 |
| CEPHALON, INC. | 4 | 2009–2010 |
| PB CONSULT | 4 | 2005 |
| SHIRE PHARMACEUTICALS LLC FORMERLY KNOWN AS SHIRE REGENERATIVE MEDICINE | 4 | 2010–2011 |
| STANLEY BLACK & DECKER INC | 4 | 2008 |
| COALITION OF AIR MEDICAL COMPANIES | 3 | 2008–2009 |
| KALLNER LAW OFFICES OF MATT | 3 | 2006–2007 |
| PHRMA | 3 | 2007–2008 |
| PYRAMID MANAGEMENT GROUP INC | 3 | 2004–2005 |
| QUANTUM LEAP INNOVATIONS, INC. | 3 | 2006–2007 |
| SOLAROVER, INC. | 3 | 2009 |
| TAKEDA PHARMACEUTICALS AMERICA INC | 3 | 2010 |
| TE CONNECTIVITY, INC. | 3 | 2011 |
| AMERICAN COUNCIL OF LIFE INSURERS | 2 | 2011 |
| CHURCH ALLIANCE | 2 | 2006–2007 |
| CITY OF CEDAR RAPIDS, IA | 2 | 2011 |
| DUPONT AND RADLAUER | 2 | 2006–2007 |
| ENDOCARE INC | 2 | 2009 |
| GENERAL ELECTRIC COMPANY (PREVIOUSLY REPORTED AS GE AVIATION) | 2 | 2011 |
| KAHO'OLAWE ISLAND RESERVE COMMISSION | 2 | 2002–2006 |
| NAVISTAR | 2 | 2007 |
| PRECISION JET MANAGEMENT | 2 | 2004 |
| SMITHFIELD FOODS INC | 2 | 2011 |
| STATE OF HAWAII DEPT OF TRANSPORTATION | 2 | 2002 |
| BASS ENTERPRISES PRODUCTION | 1 | 2003 |
| CHENIERE ENERGY | 1 | 2006 |
| CIGNA CORP | 1 | 2002 |
| E*TRADE GROUP | 1 | 2006 |
| EZENIA | 1 | 2004 |
| GE CORPORATE AVIATION SERVICES | 1 | 2003 |
| GE PIPELINE NORTH AMERICA | 1 | 2003 |
| MCQ INC. | 1 | 2004 |
| MJM ENTERPRISES & DEVELOPMENT | 1 | 2003 |
| PACIFIC MARINE & SUPPLY CO | 1 | 2003 |
| PEROT SYSTEMS GOVT SERVICES | 1 | 2005 |
| PYROLANCE NA | 1 | 2008 |
| U S ISRAEL SCIENCE AND TECHNOLOGY FOUNDATION | 1 | 2009 |
| VIRGINIA BIOTECHNOLOGY RESEARCH PARK | 1 | 2005 |
FFSCC Charter Act of 2011
Client: CASH AMERICA INTERNATIONAL, INC. · Firm: WILLIAMS AND JENSEN, PLLC
passage of H.R. 1909; and issues related to small dollar single payment and installment loan and pawn issues
FFSCC Charter Act of 2011
Client: CASH AMERICA INTERNATIONAL, INC. · Firm: WILLIAMS AND JENSEN, PLLC
passage of H.R. 1909; and issues related to payday loan and pawn issues
Joining Forces for Military Mental Health Act
Client: COCA-COLA COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
Nutritional Issues. H.R. 2751, S. 510.
Savings Enhancement for Education in College Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
529 Plan issues H.R. 529, Savings Enhancement for Education and College Act municipal bond tax issue
Savings Enhancement for Education in College Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
529 Plan issues H.R. 529, Savings Enhancement for Education and College Act municipal bond tax issue
S. 414, H.R. 627 - credit card practices; interchange fees; prepaid card fee; and financial regulation restructuring. Financial literacy issues.
S. 414, H.R. 627 - credit card practices; interchange fees; prepaid card fee; and financial regulation restructuring. Financial literacy issues.
Surface Transportation Safety Act of 2011
Client: NORFOLK SOUTHERN CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Surface Transportation Reauthorization legislation; H.R. 825, Surface Transportation Safety Act; High Speed Rail Projects
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: BAYER CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Legislation affecting 340B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Federal preemption for prescription drugs; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; and Prescription drug advertising.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payment Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectivess including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform; including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___ , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: BAYER CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1259, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services Act of 2009; S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___, America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine including H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization act ; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization act ; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Prescription drug advertising; animal health; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Legislation affecting 340B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Federal preemption for prescription drugs; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; and Prescription drug advertising.
Savings Enhancement for Education in College Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
529 Plan issues S. 827, Unclaimed Savings Bond Act; creating a pilot program to return unredeemed mature savings bonds H.R. 1351, Savings Enhancement for Education and College Act Notice 2009-1 on changing investment direction in 529 pleans
Savings Enhancement for Education in College Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
529 Plan issues S. 827, Unclaimed Savings Bond Act; creating a pilot program to return unredeemed mature savings bonds H.R. 1351, Savings Enhancement for Education and College Act Notice 2009-1 on changing investment direction in 529 pleans
Savings Enhancement for Education in College Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
529 Plan issues S. 827, Unclaimed Savings Bond Act; creating a pilot program to return unredeemed mature savings bonds H.R. 1351, Savings Enhancement for Education and College Act Notice 2009-1 on changing investment direction in 529 pleans
Savings Enhancement for Education in College Act
Client: NATIONAL ASSN OF STATE TREASURERS (NAST) · Firm: WILLIAMS AND JENSEN, PLLC
529 Plan issues S. 827, Unclaimed Savings Bond Act; creating a pilot program to return unredeemed mature savings bonds H.R. 1351, Savings Enhancement for Education and College Act Notice 2009-1 on changing investment direction in 529 pleans
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: WILLIAMS AND JENSEN, PLLC
Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness legislation including S. 1213, Patient-Centered Outcomes Research Act of 2009; and H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: BAYER CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1259, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services Act of 2009; S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___, America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine including H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payment Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectivess including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform; including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___ , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; and Federal preemption for prescription drugs.
Pathway for Biosimilars Act
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1259, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services Act of 2009; S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___, America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine including H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Pathway for Biosimilars Act
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payment Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectivess including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform; including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___ , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; and Federal preemption for prescription drugs.
Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness legislation including S. 1213, Patient-Centered Outcomes Research Act of 2009; and H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Legislation affecting 340B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Federal preemption for prescription drugs; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; and Prescription drug advertising.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BAYER CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1259, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services Act of 2009; S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___, America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine including H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BAYER CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: CEPHALON INC. · Firm: WILLIAMS AND JENSEN, PLLC
Legislation concerning patent settlements between brand name and generic pharmaceutical companies including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payment Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectivess including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform; including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___ , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; and Federal preemption for prescription drugs.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Legislation affecting 340B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Federal preemption for prescription drugs; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; and Prescription drug advertising.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: CEPHALON INC. · Firm: WILLIAMS AND JENSEN, PLLC
Legislation concerning patent settlements between brand name and generic pharmaceutical companies including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs; and FY 2011 Financial Services and General Government Appropriations bill.
Voluntary State Discount Prescription Drug Plan Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Medicaid drug rebates including S. 547/H.R. 904, Drug Rebate Equalization Act of 2009; H.R. 1725, Voluntary State Discount Prescription Drug Plan Act of 2009; and H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Medicare drug price negotiation, payment, and coverage including S. 330/H.R. 684, Medicare Prescription Drug Savings and Choice Act of 2009; S. 266, Medicare Prescription Drug Gap Reduction Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010.
Voluntary State Discount Prescription Drug Plan Act of 2009
Client: BAYER CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Medicaid drug rebates including S. 547/H.R. 904, Drug Rebate Equalization Act of 2009; H.R. 1725, Voluntary State Discount Prescription Drug Plan Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Medicare drug price negotiation, payment, and coverage including S. 330/H.R. 684, Medicare Prescription Drug Savings and Choice Act of 2009; S. 266, Medicare Preemption Drug Gap Reduction Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Medicare payment for diagnostic testing; and Medicare payment/coverage for telemedicine.
Voluntary State Discount Prescription Drug Plan Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Medicaid drug rebates including S. 547/H.R. 904, Drug Rebate Equalization Act of 2009; H.R. 1725, Voluntary State Discount Prescription Drug Plan Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Medicare drug price negotiation, payment, and coverage including S. 330/H.R. 684, Medicare Prescription Drug Savings and Choice Act of 2009; S. 266, Medicare Prescription Drug Gap Reduction Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010.
FDA Food Safety Modernization Act
Client: COCA-COLA COMPANY · Firm: WILLIAMS AND JENSEN, PLLC
Nutritional Issues. H.R. 2751, S. 510.
FDA Food Safety Modernization Act
Client: WINE AND SPIRITS WHOLESALERS OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
Food safety issues, H.R. 2751.
America's Affordable Health Choices Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payment Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectivess including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform; including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___ , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; and Federal preemption for prescription drugs.
America's Affordable Health Choices Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
America's Affordable Health Choices Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
America's Affordable Health Choices Act of 2009
Client: GENENTECH INC · Firm: WILLIAMS AND JENSEN, PLLC
Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness legislation including S. 1213, Patient-Centered Outcomes Research Act of 2009; and H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010.
America's Affordable Health Choices Act of 2009
Client: BAYER CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1259, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services Act of 2009; S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___, America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine including H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Comprehensive Alcohol Regulatory Effectiveness (CARE) Act of 2010
Client: WINE AND SPIRITS WHOLESALERS OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
Support state-based alcohol regulation systems, H.R. 5034, The Care Act.
Comprehensive Alcohol Regulatory Effectiveness (CARE) Act of 2010
Client: WINE AND SPIRITS WHOLESALERS OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
Support state-based alcohol regulation systems, H.R. 5034, The Care Act.
Comprehensive Alcohol Regulatory Effectiveness (CARE) Act of 2010
Client: WINE AND SPIRITS WHOLESALERS OF AMERICA · Firm: WILLIAMS AND JENSEN, PLLC
Support state-based alcohol regulation systems, H.R. 5034, The Care Act.
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: BAYER CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1259, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services Act of 2009; S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___, America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine including H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payment Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectivess including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform; including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___ , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; and Federal preemption for prescription drugs.
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: BAYER CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Legislation affecting 340B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Federal preemption for prescription drugs; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; and Prescription drug advertising.
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Legislation affecting 340B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Federal preemption for prescription drugs; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; and Prescription drug advertising.
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1259, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services Act of 2009; S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___, America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine including H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization act ; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Prescription drug advertising; animal health; and Federal preemption for prescription drugs.
School Building Enhancement Act
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization act ; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
School Building Enhancement Act
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payment Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectivess including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform; including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___ , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; and Federal preemption for prescription drugs.
School Building Enhancement Act
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Legislation affecting 340B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Federal preemption for prescription drugs; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; and Prescription drug advertising.
School Building Enhancement Act
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Legislation affecting 340B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Federal preemption for prescription drugs; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; and Prescription drug advertising.
School Building Enhancement Act
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
FFSCC Act of 2010
Client: CASH AMERICA INTERNATIONAL, INC. · Firm: WILLIAMS AND JENSEN, PLLC
passage of H.R. 5942, and issues related to payday loan and pawn issues
FFSCC Act of 2010
Client: CASH AMERICA INTERNATIONAL, INC. · Firm: WILLIAMS AND JENSEN, PLLC
passage of H.R. 5942, and issues related to payday loan and pawn issues
FFSCC Act of 2010
Client: CASH AMERICA INTERNATIONAL, INC. · Firm: WILLIAMS AND JENSEN, PLLC
passage of H.R. 5942, and issues related to payday loan and pawn issues
FFSCC Act of 2010
Client: CASH AMERICA INTERNATIONAL, INC. · Firm: WILLIAMS AND JENSEN, PLLC
passage of H.R. 5942, and issues related to payday loan and pawn issues
FFSCC Act of 2010
Client: CASH AMERICA INTERNATIONAL, INC. · Firm: WILLIAMS AND JENSEN, PLLC
passage of H.R. 5942, and issues related to payday loan and pawn issues
FFSCC Act of 2010
Client: CASH AMERICA INTERNATIONAL, INC. · Firm: WILLIAMS AND JENSEN, PLLC
passage of H.R. 5942, and issues related to payday loan and pawn issues
Medicare Prescription Drug Savings and Choice Act of 2009
Client: BAYER CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Medicaid drug rebates including S. 547/H.R. 904, Drug Rebate Equalization Act of 2009; H.R. 1725, Voluntary State Discount Prescription Drug Plan Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Medicare drug price negotiation, payment, and coverage including S. 330/H.R. 684, Medicare Prescription Drug Savings and Choice Act of 2009; S. 266, Medicare Preemption Drug Gap Reduction Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Medicare payment for diagnostic testing; and Medicare payment/coverage for telemedicine.
Medicare Prescription Drug Savings and Choice Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Medicaid drug rebates including S. 547/H.R. 904, Drug Rebate Equalization Act of 2009; H.R. 1725, Voluntary State Discount Prescription Drug Plan Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Medicare drug price negotiation, payment, and coverage including S. 330/H.R. 684, Medicare Prescription Drug Savings and Choice Act of 2009; S. 266, Medicare Prescription Drug Gap Reduction Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010.
Medicare Prescription Drug Savings and Choice Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Medicaid drug rebates including S. 547/H.R. 904, Drug Rebate Equalization Act of 2009; H.R. 1725, Voluntary State Discount Prescription Drug Plan Act of 2009; and H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Medicare drug price negotiation, payment, and coverage including S. 330/H.R. 684, Medicare Prescription Drug Savings and Choice Act of 2009; S. 266, Medicare Prescription Drug Gap Reduction Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010.
Stem Cell Research Enhancement Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Stem Cell Research Enhancement Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Medicaid Prescription Drug Rebate Equalization Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Medicaid drug rebates including S. 547/H.R. 904, Drug Rebate Equalization Act of 2009; H.R. 1725, Voluntary State Discount Prescription Drug Plan Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Medicare drug price negotiation, payment, and coverage including S. 330/H.R. 684, Medicare Prescription Drug Savings and Choice Act of 2009; S. 266, Medicare Prescription Drug Gap Reduction Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010.
Medicaid Prescription Drug Rebate Equalization Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Medicaid drug rebates including S. 547/H.R. 904, Drug Rebate Equalization Act of 2009; H.R. 1725, Voluntary State Discount Prescription Drug Plan Act of 2009; and H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Medicare drug price negotiation, payment, and coverage including S. 330/H.R. 684, Medicare Prescription Drug Savings and Choice Act of 2009; S. 266, Medicare Prescription Drug Gap Reduction Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010.
Medicaid Prescription Drug Rebate Equalization Act of 2009
Client: BAYER CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Medicaid drug rebates including S. 547/H.R. 904, Drug Rebate Equalization Act of 2009; H.R. 1725, Voluntary State Discount Prescription Drug Plan Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Medicare drug price negotiation, payment, and coverage including S. 330/H.R. 684, Medicare Prescription Drug Savings and Choice Act of 2009; S. 266, Medicare Preemption Drug Gap Reduction Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Medicare payment for diagnostic testing; and Medicare payment/coverage for telemedicine.
Patient-Centered Outcomes Research Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Patient-Centered Outcomes Research Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payment Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectivess including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform; including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___ , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; and Federal preemption for prescription drugs.
Patient-Centered Outcomes Research Act of 2009
Client: GENENTECH INC · Firm: WILLIAMS AND JENSEN, PLLC
Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness legislation including S. 1213, Patient-Centered Outcomes Research Act of 2009; and H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010.
Patient-Centered Outcomes Research Act of 2009
Client: BAYER CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1259, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services Act of 2009; S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___, America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine including H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Patient-Centered Outcomes Research Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization act ; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Prescription drug advertising; animal health; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization act ; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: PFIZER · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: BAYER CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1259, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services Act of 2009; S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___, America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine including H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Legislation affecting 340B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Federal preemption for prescription drugs; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; and Prescription drug advertising.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, the Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payment Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectivess including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform; including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___ , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; and Federal preemption for prescription drugs.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: BAYER CORPORATION · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: WILLIAMS AND JENSEN, PLLC
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Legislation affecting 340B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Federal preemption for prescription drugs; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; and Prescription drug advertising.
General corporate tax issues; VEBA; international tax issues. S. 727, VEBA provision.
Legislation regarding labor issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
NORFOLK SOUTHERN CORPORATION via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Surface Transportation Reauthorization legislation; rail related funding; and Rail Surface Transportation Safety Act.
Filing targets: Federal Railroad Administration, HOUSE OF REPRESENTATIVES, SENATE
WINE AND SPIRITS WHOLESALERS OF AMERICA via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
General issues related to domestic wine and spirit industry. Excise taxes and accounting tax issues. Estate tax reform.
Support state-based alcohol regulation systems, H.R. 1611, The Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VISA via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
S. 414, H.R. 627 - credit card practices; interchange fees; prepaid card fee; and financial regulation restructuring. Financial literacy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TE CONNECTIVITY, INC. via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Defense appropriations
Federal contracting issues; international tax on foreign direct investment and general corporate tax issues.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
PFIZER via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Drug safety and drug counterfeiting; Drug importation; Prescription drug advertising; animal health; and Federal preemption for prescription drugs. Rebates for Medicare Part D.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL ELECTRIC COMPANY (PREVIOUSLY REPORTED AS GE AVIATION) via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Continued funding of GE F136 Joint Strike Fighter
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSN OF STATE TREASURERS (NAST) via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
529 Plan issues H.R. 529, Savings Enhancement for Education and College Act municipal bond tax issue
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
SMITHFIELD FOODS, INC. via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Food safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED AIRLINES INC via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
antitrust/merger
Transportation appropriations, FAA reauthorization, and Homeland Security issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COUNCIL OF LIFE INSURERS via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Financial Services legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRANSAMERICA COMPANIES (FORMLY AEGON) via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Financial Services legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CASH AMERICA INTERNATIONAL, INC. via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
passage of H.R. 1909; and issues related to payday loan and pawn issues
passage of H.R. 1909; and issues related to small dollar single payment and installment loan and pawn issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HONOLULU AUTH. FOR RAPID TRNS. (PREVIOUSLY KNOWN AS INFRACONSULT, LLC.) via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Authorization and appropriations legislation for transportation infrastructure projects.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELL INC via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Information technology legislation and appropriations legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUNTY OF MAUI- HAWAII via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Transportation and Infrastructure funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CITY OF NEW HAVEN CONNECTICUT via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Transportation and economic development legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CELLULAR BIOENGINEERING INC via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
DoD and DoE research and development programs
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
BI-STATE DEVELOPMENT AGENCY D/B/A ST LOUIS METRO via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Federal transit funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE INTERNET & TELEVISION ASSN (FORMERLY NTL CABLE & TELECOMMUNICATIONS ASSN) via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Legislation affecting multichannel TV, broadband, telephony, and the Internet, including taxation, intellectual property and regulatory issues, state taxation of cable TV and DBS.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIGHT HOUSE NETWORKS via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Legislation affecting multichannel TV, broadband, telephony, and the Internet, including intellectual property and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLUMBUS REGIONAL AIRPORT AUTHORITY via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
General transportation issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIPPO MANUFACTURING COMPANY via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
regulation of lighters.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VICTORINOX SWISS ARMY via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
TSA Regulations regarding carry-on articles on commercial aircraft.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation Security Administration (TSA)
LEATHERMAN TOOL GROUP INC via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
TSA Regulations regarding carry-on items on commercial aircraft.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Legislation affecting multichannel TV, broadband, telephony, and the Internet, including intellectual property and regulatory issues. Comcast NBCU transaction.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TTX COMPANY via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · Q2
Rail re-regulation proposals; rail security legislation; truck size and weight issues; Rail safety legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CITY OF CEDAR RAPIDS, IA via WILLIAMS AND JENSEN, PLLC
2011 · second_quarter · 2T
flood control
Filing targets: General Services Administration (GSA), HOUSE OF REPRESENTATIVES, SENATE
TE CONNECTIVITY, INC. via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Defense appropriations
Federal contracting issues; international tax on foreign direct investment and general corporate tax issues.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
WINE AND SPIRITS WHOLESALERS OF AMERICA via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
General issues related to domestic wine and spirit industry. Excise taxes and accounting tax issues. Estate tax reform.
Support state-based alcohol regulation systems, H.R. 1611, The Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VISA via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
S. 414, H.R. 627 - credit card practices; interchange fees; prepaid card fee; and financial regulation restructuring. Financial literacy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Drug safety and drug counterfeiting; Drug importation; Prescription drug advertising; animal health; and Federal preemption for prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSN OF STATE TREASURERS (NAST) via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
529 Plan issues H.R. 529, Savings Enhancement for Education and College Act municipal bond tax issue
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
GENERAL ELECTRIC COMPANY (PREVIOUSLY REPORTED AS GE AVIATION) via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Continued funding of GE F136 Joint Strike Fighter
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TE CONNECTIVITY, INC. via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · RR
Federal contracting issues, international tax on foreign direct investment, and general corporate tax issues. Taiwan customs issue. Defense appropriations.
Federal contracting issues, international tax on foreign direct investment, and general corporate tax issues. Taiwan customs issue. Defense appropriations.
Federal contracting issues, international tax on foreign direct investment, and general corporate tax issues. Taiwan customs issue. Defense appropriations.
TYCO ELECTRONICS via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · 1T
Federal contracting issues; international tax on foreign direct investment and general corporate tax issues.
Defense appropriations
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ZIPPO MANUFACTURING COMPANY via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
regulation of lighters.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VICTORINOX SWISS ARMY via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
TSA Regulations regarding carry-on articles on commercial aircraft.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation Security Administration (TSA)
INTERNATIONAL ASSOCIATION OF AMUSEMENT PARKS AND ATTRACTIONS via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Matters affecting the amusement parks and attractions industry, including implementation of Public Law 110-314; federal jurisdiction.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LEATHERMAN TOOL GROUP INC via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
TSA Regulations regarding carry-on items on commercial aircraft.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FP2 INC. via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Pavement preservation issues in the surface transportation reauthorization bill and transportation appropriations bills including the Surface Transportation Authorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRINKS COMPANY via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Legislation regarding labor issues
General corporate tax issues; VEBA; international tax issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Medicare prescription drug benefit.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORFOLK SOUTHERN CORPORATION via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Surface Transportation Reauthorization legislation; H.R. 825, Surface Transportation Safety Act; High Speed Rail Projects
Filing targets: Federal Railroad Administration, HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Legislation affecting multichannel TV, broadband, telephony, and the Internet, including intellectual property and regulatory issues. Comcast NBCU transaction.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CASH AMERICA INTERNATIONAL, INC. via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
work on passage of legislation regarding providing financial services to unbanked and underbanked consumers, including small, short term loans, payday loans and other products
work on passage of legislation regarding providing financial services to unbanked and underbanked consumers, including small, short term loans, payday loans and other products
Filing targets: HOUSE OF REPRESENTATIVES
GENENTECH INC via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Issues concerning clinical trials. Implementation of Patient Protection and Affordable Care Act. Congressional oversight issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE PHARMACEUTICALS LLC FORMERLY KNOWN AS SHIRE REGENERATIVE MEDICINE via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Disaster preparedness
payment policy for diabetes product
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITHFIELD FOODS, INC. via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Food safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED AIRLINES INC via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
antitrust/merger
Transportation appropriations, FAA reauthorization, and Homeland Security issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COCA-COLA COMPANY via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Nutritional Issues. H.R. 2751, S. 510.
Tax legislation including issues pertaining to beverage tax, international tax issues in the FY 2011 Administration Budget.
Environmental issues impacting the beverage industry and commodity pricing legislation.
AMERICAN COUNCIL OF LIFE INSURERS via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Financial Services legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRANSAMERICA COMPANIES (FORMLY AEGON) via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Financial Services legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HONOLULU AUTH. FOR RAPID TRNS. (PREVIOUSLY KNOWN AS INFRACONSULT, LLC.) via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Authorization and appropriations legislation for transportation infrastructure projects.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELL INC via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Information technology legislation and appropriations legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUNTY OF MAUI- HAWAII via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Transportation and Infrastructure funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CITY OF NEW HAVEN CONNECTICUT via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Transportation and economic development legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CELLULAR BIOENGINEERING INC via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
DoD and DoE research and development programs
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
BI-STATE DEVELOPMENT AGENCY D/B/A ST LOUIS METRO via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Federal transit funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE INTERNET & TELEVISION ASSN (FORMERLY NTL CABLE & TELECOMMUNICATIONS ASSN) via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Legislation affecting multichannel TV, broadband, telephony, and the Internet, including taxation, intellectual property and regulatory issues, state taxation of cable TV and DBS.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIGHT HOUSE NETWORKS via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Legislation affecting multichannel TV, broadband, telephony, and the Internet, including intellectual property and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLUMBUS REGIONAL AIRPORT AUTHORITY via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
General transportation issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TTX COMPANY via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
Rail re-regulation proposals; rail security legislation; truck size and weight issues; Rail safety legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CITY OF CEDAR RAPIDS, IA via WILLIAMS AND JENSEN, PLLC
2011 · first_quarter · Q1
flood control
Filing targets: General Services Administration (GSA), HOUSE OF REPRESENTATIVES, SENATE
HONOLULU AUTH. FOR RAPID TRNS. (PREVIOUSLY KNOWN AS INFRACONSULT, LLC.) via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Authorization and appropriations legislation for transportation infrastructure projects.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELL INC via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Information technology legislation and appropriations legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUNTY OF MAUI- HAWAII via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Transportation and Infrastructure funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CITY OF NEW HAVEN CONNECTICUT via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Transportation and economic development legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CELLULAR BIOENGINEERING INC via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
DoD and DoE research and development programs
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
BI-STATE DEVELOPMENT AGENCY D/B/A ST LOUIS METRO via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Federal transit funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN RED CROSS, CINCINNATI AREA CHAPTER via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
appropriations requests for a new building
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CASH AMERICA INTERNATIONAL, INC. via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
passage of H.R. 5942, and issues related to payday loan and pawn issues
passage of H.R. 5942, and issues related to payday loan and pawn issues
Filing targets: HOUSE OF REPRESENTATIVES
ZIPPO MANUFACTURING COMPANY via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
regulation of lighters.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VICTORINOX SWISS ARMY via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
TSA Regulations regarding carry-on articles on commercial aircraft.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation Security Administration (TSA)
INTERNATIONAL ASSOCIATION OF AMUSEMENT PARKS AND ATTRACTIONS via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Matters affecting the amusement parks and attractions industry, including implementation of Public Law 110-314; federal jurisdiction.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LEATHERMAN TOOL GROUP INC via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
TSA Regulations regarding carry-on items on commercial aircraft.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TAKEDA PHARMACEUTICALS AMERICA, INC. via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Legislation affecting 340B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Federal preemption for prescription drugs; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; and Prescription drug advertising.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CEPHALON INC. via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Legislation concerning patent settlements between brand name and generic pharmaceutical companies including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs; and FY 2011 Financial Services and General Government Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER CORPORATION via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
Medicare payment for diagnostic testing. Medicare payment/coverage for telemedicine.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Medicare prescription drug benefit
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.
OWENS-ILLINOIS INC via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Environmental legislation impacting the manufacturing sector, including EPA regulation moratorium; The American Clean Energy and Security Act of 2009; and the American Power Act of 2010, energy intensive manufacturer issues; recycling issues.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
NORFOLK SOUTHERN CORPORATION via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Railroad/STB regulatory reform/reathorization; S. 146, the Railroad Antitrust Enforcement Act; Rail facility appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Issues concerning clinical trials. General health care reform (Patient Protection and Affordable Care Act). Congressional oversight issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE PHARMACEUTICALS LLC FORMERLY KNOWN AS SHIRE REGENERATIVE MEDICINE via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
payment policy for diabetes product
Disaster preparedness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WINE AND SPIRITS WHOLESALERS OF AMERICA via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
General issues related to domestic wine and spirit industry. Excise taxes and accounting tax issues. Estate tax reform.
Food safety issues, H.R. 2751.
Support state-based alcohol regulation systems, H.R. 5034, The Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VISA via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
S. 414, H.R. 627 - credit card practices; interchange fees; prepaid card fee; and financial regulation restructuring. Financial literacy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TYCO ELECTRONICS via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Federal contracting issues; international tax on foreign direct investment and general corporate tax issues.
Defense appropriations
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
PFIZER via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Drug safety and drug counterfeiting; Drug importation; Prescription drug advertising; animal health; and Federal preemption for prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSN OF STATE TREASURERS (NAST) via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
529 Plan issues S. 827, Unclaimed Savings Bond Act; creating a pilot program to return unredeemed mature savings bonds H.R. 1351, Savings Enhancement for Education and College Act Notice 2009-1 on changing investment direction in 529 pleans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
UNITED AIRLINES INC via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
general trade issues
antitrust/merger
Transportation appropriations, FAA reauthorization, and Homeland Security issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COCA-COLA COMPANY via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Tax legislation including issues pertaining to beverage tax, international tax issues in the FY 2011 Administration Budget.
renewable energy issues
Nutritional Issues. H.R. 2751, S. 510.
THE INTERNET & TELEVISION ASSN (FORMERLY NTL CABLE & TELECOMMUNICATIONS ASSN) via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Legislation affecting multichannel TV, broadband, telephony, and the Internet, including taxation, intellectual property and regulatory issues, state taxation of cable TV and DBS.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIGHT HOUSE NETWORKS via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Legislation affecting multichannel TV, broadband, telephony, and the Internet, including intellectual property and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLUMBUS REGIONAL AIRPORT AUTHORITY via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
General transportation issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TTX COMPANY via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Rail re-regulation proposals; rail security legislation; truck size and weight issues; Rail safety legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Legislation affecting multichannel TV, broadband, telephony, and the Internet, including intellectual property and regulatory issues. Comcast NBCU transaction.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRINKS COMPANY via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Legislation regarding labor issues
General corporate tax issues; VEBA; international tax issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
FP2 INC. via WILLIAMS AND JENSEN, PLLC
2010 · fourth_quarter · Q4
Pavement preservation issues in the surface transportation reauthorization bill and transportation appropriations bills including the Surface Transportation Authorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLUMBUS REGIONAL AIRPORT AUTHORITY via WILLIAMS AND JENSEN, PLLC
2010 · third_quarter · Q3
General transportation issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
renewable energy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Environmental issues impacting the beverage industry and commodity pricing legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE